Michael Gold to Cardiac Resynchronization Therapy Devices
This is a "connection" page, showing publications Michael Gold has written about Cardiac Resynchronization Therapy Devices.
Connection Strength
3.182
-
The effect of posture, exercise, and atrial pacing on atrioventricular conduction in systolic heart failure. J Cardiovasc Electrophysiol. 2019 12; 30(12):2892-2899.
Score: 0.653
-
Biventricular pacemaker/defibrillators versus biventricular pacemakers in patients with non-ischemic cardiomyopathy. Card Electrophysiol Clin. 2015 Sep; 7(3):455-9.
Score: 0.482
-
Optimization of cardiac resynchronization therapy: importance of programmed parameters. J Cardiovasc Electrophysiol. 2012 Jan; 23(1):110-8.
Score: 0.378
-
Microbiologic characteristics and antimicrobial susceptibility of pacemaker/ICD infections: a moving target! J Cardiovasc Electrophysiol. 2012 Apr; 23(4):382-3.
Score: 0.375
-
Role of Electrical Delay in Cardiac Resynchronization Therapy Response. Card Electrophysiol Clin. 2022 06; 14(2):233-241.
Score: 0.195
-
The cost of non-response to cardiac resynchronization therapy: characterizing heart failure events following cardiac resynchronization therapy. Europace. 2021 10 09; 23(10):1586-1595.
Score: 0.186
-
Evaluation, Management, and Outcomes of Patients Poorly Responsive to Cardiac?Resynchronization Device Therapy. J Am Coll Cardiol. 2019 11 26; 74(21):2588-2603.
Score: 0.164
-
Design and rationale for the Stimulation Of the Left Ventricular Endocardium for Cardiac Resynchronization Therapy in non-responders and previously untreatable patients (SOLVE-CRT) trial. Am Heart J. 2019 11; 217:13-22.
Score: 0.157
-
The Impact of the PR Interval in Patients?Receiving Cardiac Resynchronization Therapy: Results From the REVERSE Study. JACC Clin Electrophysiol. 2017 08; 3(8):818-826.
Score: 0.137
-
Economic Value and Cost-Effectiveness of?Cardiac Resynchronization Therapy Among Patients With Mild Heart Failure: Projections From the REVERSE Long-Term Follow-Up. JACC Heart Fail. 2017 03; 5(3):204-212.
Score: 0.134
-
Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial. Eur Heart J. 2012 Nov; 33(21):2662-71.
Score: 0.095
-
Acute clinical evaluation of a left ventricular automatic threshold determination algorithm based on evoked response sensing. Pacing Clin Electrophysiol. 2012 Mar; 35(3):348-56.
Score: 0.094
-
Effectiveness of Cardiac Resynchronization Therapy by QRS Morphology in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT). Circulation. 2011 Mar 15; 123(10):1061-72.
Score: 0.089
-
Economic implications of adding a novel algorithm to optimize cardiac resynchronization therapy: rationale and design of economic analysis for the AdaptResponse trial. J Med Econ. 2020 Dec; 23(12):1401-1408.
Score: 0.044